Alessandro Capucci.

Jeff S. Healey, M.D Get more information ., Stuart J. Connolly, M.D., Michael R. Gold, M.D., Carsten W. Israel, M.D., Isabelle C. Van Gelder, M.D., Alessandro Capucci, M.D., C.P. Lau, M.D., Eric Fain, M.D., Sean Yang, M.Sc., Christophe Bailleul, M.D., Carlos A. Morillo, M.D., Tag Carlson, M.D., Ellison Themeles, M.Sc., Elizabeth S. Kaufman, M.D., and Stefan H. Hohnloser, M.D. For the ASSERT Investigators: Subclinical Atrial Fibrillation and the chance of Stroke Atrial fibrillation could be asymptomatic and subclinical consequently.1,2 Epidemiologic studies indicate that many individuals with atrial fibrillation on screening electrocardiograms had not previously received a medical diagnosis of atrial fibrillation.3 About 15 percent of strokes are attributable to documented atrial fibrillation, and 50 to 60 percent to documented cerebrovascular disease,4-7 but in about 25 percent of patients who have ischemic strokes, zero etiologic factor is determined.

There were no significant variations in polysomnographic variables between the two groups, however . Seventy-five of the 86 sufferers experienced the metabolic syndrome at the time of recruitment . Aftereffect of Intervention on the Metabolic Syndrome Seventy-one of 86 patients had the metabolic syndrome in the beginning of CPAP therapy, in comparison with 70 of 86 patients at the start of sham CPAP. The frequency of the metabolic syndrome decreased after CPAP therapy in comparison with sham CPAP . After CPAP therapy, 14 of the 71 individuals with the metabolic syndrome no more fulfilled the criteria for the syndrome, while symptoms of the syndrome developed in 3 of the 15 patients without the metabolic syndrome in the beginning.